Clinical Trial Update: Use of Hair to Diagnose Breast Cancer [Phase 2]

View source ↗

Summary

The document reports an ongoing Phase 2 trial sponsored by Fermiscan Ltd evaluating the use of hair analysis to diagnose breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fermiscan Ltd | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN